Ascletis Adds Support to $100 Million in Startup Capital

Ascletis, a US-China drug development startup, announced new support from the two cities in which it will do business – Hangzhou, China, and Research Triangle Park, US. One feature of the new agreements is clear: Ascletis will house a US-based R&D center in the Research Triangle’s Hamner Institutes. Beyond that, there aren’t many specifics in the agreements, beyond access to the networks of The Hamner and Hangzhou Hi-Tech Industry Development Zone. More details....